07:00 AM EDT, 10/29/2024 (MT Newswires) -- Pfizer ( PFE ) reported Q3 adjusted earnings Tuesday of $1.06 per diluted share, swinging from an adjusted loss of $0.17 a year earlier.

Analysts polled by Capital IQ expected an adjusted EPS of $0.61.

Revenue for the quarter was $17.7 billion, up from $13.49 billion a year earlier.

Analysts polled by Capital IQ expected $14.87 billion.

The company said it has raised its 2024 adjusted EPS outlook to $2.75 to $2.95, up from the previous range of $2.45 to $2.65.

Revenue for the year is now projected to be $61 billion to $64 billion, up from $59.5 billion to $62.5 billion previously, the company said. Analysts polled by Capital IQ expect $2.66 in adjusted EPS on revenue of $61.06 billion.

Price: 29.73, Change: +0.87, Percent Change: +3.01